首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Drug utilization studies: a tool for determining the effectiveness of drug use.
【2h】

Drug utilization studies: a tool for determining the effectiveness of drug use.

机译:药物利用研究:一种确定药物使用有效性的工具。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To evaluate the quality of the consumption of medicines in Spain, its potential efficacy, and its evolution during the last years, an assessment of the 'intrinsic value' of the most sold pharmaceutical specialities (amounting to more than 50% of total pharmaceutical market) was carried out. A panel of five clinical pharmacologist classified medicines, according to their intrinsic value, in four groups: (i) 'high value' (41% of analyzed medicines in 1980); (ii) 'relative value' (12% in 1980); (iii) 'doubtful value' (3%); (iv) 'no value' (23%), and (v) 'unacceptable value' (21%). Drugs were also classified according to their expected potential of use; and three groups were formed: (i) 'high' (32%); (ii) 'relatively high' (14%), and (iii) 'reduced' (10%). A fourth group of 'not applicable' (44%) in this classification was formed with pharmaceuticals considered unvaluable or unacceptable in the first classification. The results of this study suggest that this kind of analysis may be a useful tool to evaluate the efficacy of drugs in the community, and to identify priorities and guidelines in the selection of drugs in each country.
机译:为了评估西班牙药品消费的质量,其潜在功效及其在过去几年中的发展,对最畅销的药品专业的“内在价值”进行了评估(占整个药品市场的50%以上)进行了。由五名临床药理学家组成的小组根据其内在价值将其分为四类:(i)“高价值”(1980年占分析药物的41%); (ii)“相对价值”(1980年为12%); (iii)“可疑价值”(3%); (iv)“无价值”(23%)和(v)“不可接受的价值”(21%)。药物也根据其预期的使用潜力进行分类。形成了三组:(i)“高”(32%); (ii)“相对较高”(14%)和(iii)“减少”(10%)。第四类“不适用”(44%)是由第一类中被认为不可估量或不可接受的药品组成的。这项研究的结果表明,这种分析可能是一个有用的工具,可以用来评估社区中药物的功效,并确定每个国家在选择药物时的优先事项和指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号